Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study

被引：0
|
作者：
Ennio Lubrano
Fabio Massimo Perrotta
Maria Manara
Salvatore D’Angelo
Roberta Ramonda
Leonardo Punzi
Olga Addimanda
Carlo Salvarani
Antonio Marchesoni
机构：
[1] Università degli Studi del Molise,Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”
[2] ASST Centro Specialistico Ortopedico Traumatologico G. Pini-CTO,Day Hospital di Reumatologia
[3] San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera,Rheumatology Department of Lucania
[4] University of Padova,Rheumatology Unit, Department of Clinical and Experimental Medicine DIMED
[5] Università di Bologna,SSD di Medicina e Reumatologia, Istituto Ortopedico Rizzoli
[6] Azienda Ospedaliera-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia,Rheumatology Unit
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Axial spondyloarthritis; Anti-TNF; Function; Outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：301 / 310
页数：9
相关论文
共 50 条
  • [21] EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN AXIAL SPONDYLOARTHRITIS: A 24-MONTH PROSPECTIVE, MULTICENTER REAL-LIFE STUDY
    Cozzi, G.
    Lorenzin, M.
    Chimenti, M. S.
    D'angelo, S.
    Marchesoni, A.
    Salvarani, C.
    Lubrano, E.
    Costa, L.
    Dal Bosco, Y.
    Fracassi, E.
    Ortolan, A.
    Ferraioli, M.
    Carriero, A.
    Visalli, E.
    Bixio, R.
    Desiati, F.
    Bergamini, A.
    Pedrollo, E.
    Doria, A.
    Foti, R.
    Carletto, A.
    Ramonda, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 395 - 395
  • [22] Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study
    Hurtubise, Raphael
    Rohekar, Sherry
    Haroon, Nigil
    Baskurt, Zeynep
    Chim, Tina
    Zummer, Michel
    Inman, Robert D.
    Richard, Nicolas
    SpondyloArthritis Research Consortium Canada SPARCC, Robert D.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2025, 9 (01)
  • [23] Effectiveness and safety of secukinumab in axial, spondyloarthritis: a 24-month prospective, multicenter real-life study
    Ramonda, Roberta
    Lorenzin, Mariagrazia
    Chimenti, Maria Sole
    D'Angelo, Salvatore
    Marchesoni, Antonio
    Salvarani, Carlo
    Lubrano, Ennio
    Costa, Luisa
    Dal Bosco, Ylenia
    Fracassi, Elena
    Ortolan, Augusta
    Ferraioli, Mario
    Carriero, Antonio
    Visalli, Elisa
    Bixio, Riccardo
    Desiati, Francesca
    Bergamini, Alberto
    Pedrollo, Elisa
    Doria, Andrea
    Foti, Rosario
    Carletto, Antonio
    Spadaro, Antonio
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [24] REAL-LIFE EVALUATION OF HEALTH STATUS USING ASAS HEALTH INDEX ON PATIENTS WITH AXIAL AND PERIPHERAL SPONDYLOARTHRITIS IN ARGENTINA
    Martire, V.
    Girard Bosch, P.
    Airoldi, C.
    Benegas, M.
    Cosentino, V.
    Marin, J.
    Duarte, V.
    Bande, J. M.
    Gamba, M. J.
    Sommerfleck, F.
    Gonzalez, P.
    Vila, D.
    Oliver, M.
    Garcia, L.
    Velozo, E.
    Kerzberg, E.
    Tapia, J.
    Cosatti, M.
    Giorgis, P.
    Macias Oviedo, L. L.
    Schneeberger, E.
    Nieto, R.
    Garcia, M.
    Scarafia, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 746 - 747
  • [25] Rapid improvement in pruritus in atopic dermatitis patients treated with upadacitinib: a real-life experience
    Napolitano, M.
    Fabbrocini, G.
    Genco, L.
    Martora, F.
    Potestio, L.
    Patruno, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (09) : 1497 - 1498
  • [26] Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
    Emine Duran
    Zeynep Ozge Ozturk
    Emre Bilgin
    Yahya Büyükaşık
    Omer Dizdar
    Gozde Kubra Yardimci
    Bayram Farisogullari
    Zehra Özsoy
    Gizem Ayan
    Gullu Sandal Uzun
    Mustafa Ekici
    Erdinc Unaldi
    Levent Kilic
    Ali Akdoğan
    Omer Karadag
    Şule Apraş Bilgen
    Sedat Kiraz
    Umut Kalyoncu
    Ali Ihsan Ertenli
    Rheumatology and Therapy, 2023, 10 : 969 - 981
  • [27] THE INCIDENCE AND RISK FACTORS FOR ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A REAL-LIFE STUDY
    Guven, Deniz Can
    Ozbek, Deniz Aral
    Sahin, Taha Koray
    Aksun, Melek Seren
    Kavgaci, Gozde
    Cebrayilov, Cebrayil
    Yildirim, Tolga
    Dizdar, Omer
    Aksoy, Sercan
    Kilickap, Saadettin
    Yalcin, Suayib
    Erman, Mustafa
    Arici, Mustafa
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [28] Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
    Duran, Emine
    Ozturk, Zeynep Ozge
    Bilgin, Emre
    Buyukasik, Yahya
    Dizdar, Omer
    Yardimci, Gozde Kubra
    Farisogullari, Bayram
    Ozsoy, Zehra
    Ayan, Gizem
    Uzun, Gullu Sandal
    Ekici, Mustafa
    Unaldi, Erdinc
    Kilic, Levent
    Akdogan, Ali
    Karadag, Omer
    Bilgen, Sule Apras
    Kiraz, Sedat
    Kalyoncu, Umut
    Ertenli, Ali Ihsan
    RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 969 - 981
  • [29] Clinical and structural damage outcomes in axial spondyloarthritis patients receiving NSAIDs or advanced therapies: a description of a real-life cohort
    Mocritcaia, Anastasia
    Chacur, Chafik
    Abe, C. D. Adao
    Azuaga-Pinango, Ana Belen
    Frade-Sosa, Beatriz
    Sarmiento-Monroy, Juan C.
    Alascio, Lucia
    Gomez-Puerta, J. A.
    Sanmarti, Raimon
    Canete, Juan D.
    Ramirez, Julio
    FRONTIERS IN MEDICINE, 2024, 11
  • [30] SURVIVAL ANALYSIS AND REASONS FOR DISCONTINUING OR SWITCHING TUMOUR NECROSIS FACTOR INHIBITORS IN AXIAL SPONDYLOARTHRITIS: FINDINGS FROM A REAL-LIFE UK COHORT
    Yahya, Fariz
    Gaffney, Karl
    Lonsdale, Ellie
    Leeder, Jane
    Brooksby, Alan
    Berry-Jenkins, Joshua
    Boyle, Cathal
    Bond, Debbie
    Cavill, Charlotte
    Sengupta, Raj
    RHEUMATOLOGY, 2017, 56 : 95 - 95
12345